Susquehanna International Group, LLP Beyond Spring Inc. Put Options Transaction History

Susquehanna International Group, LLP

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2023 Aug 11, 2023	SELL	$0.89 - $1.39 $3,293 - $5,143	-3,700 Reduced 15.48%	20,200 $23,000
Q1 2023 May 16, 2023	SELL	$1.06 - $3.05 $52,682 - $151,585	-49,700 Reduced 67.53%	23,900 $26,000
Q4 2022 Feb 14, 2023	BUY	$0.56 - $2.61 $13,160 - $61,335	23,500 Added 46.91%	73,600 $138,000
Q3 2022 Nov 14, 2022	SELL	$1.06 - $1.81 $28,408 - $48,508	-26,800 Reduced 34.85%	50,100 $50,000

5.44M

30.3K

1.8K

Ticker BYSI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,928,900
Market Cap $88.4M
Description
BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.